SBIR/STTR Research Award

Bioabsorbable Membranes for Prevention of Adhesions

Award identifier b06120ec2a23e3bf1e58d51bcba3c08bcaad972713f3d967d386166871f79322Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,283,550

Program and phase

SBIR · Phase II

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
STONYBROOK TECHNOLOGY/APPLIED RESEARCH
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Stonybrook Technology and Applied Research (STAR), Inc. is currently focused on the development of unique anti-adhesion nanostructured products in post-operative surgery. Adhesions are mainly induced from the trauma of surgery and can lead to serious complications, including pelvic pain, small bowel obstruction, female infertility, chronic debilitating pain and difficulty with future operations. Typically, a patient will often undergo surgery to remove adhesions, only to have them reform. It is a very costly problem, e.g., Medicare alone has paid $3.22 billion per year for the treatment of adhesion related complications in the 1990's. In this SBIR Phase II submission to the NIGMS, STAR is seeking 3 years of support to complete the development of two FDA-regulated anti-adhesion products: (1) unsupported membranes for abdominal surgery and (2) mesh supported membranes for hernia repair. The specific aims of this application are: 1. Thorough in vivo studies using rat and rabbit models to evaluate the proposed two anti-adhesion products. 2. Introduction of medicated alternatives and composition adjustments as contingency plans. 3. Development of mass production facility using multiple-jet electro-spinning technology to commercialize anti-adhesion products. Thus, in the Phase II project, the proposed tasks will deal mainly with the completion of: 1. In vivo studies using the objective rat model and the rabbit model to evaluate the anti-adhesion properties of two electro-spun non-medicated products based on a successful chemical composition. 2. Optimization of non-medicated anti-adhesion products by fine tuning of the PEG composition using in vitro and in vivo evaluations as a first contingency plan. 3. Optimization of medicated anti-adhesion products by determining the minimum effective dosage of Cefoxitin sodium for local delivery based on in vivo evaluation as a second contingency plan. 4. Development of scale-up instrumentation by the implementation of electro-blowing technology, robust linear fluid delivery system, uniform thickness production and system integration.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.